BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36451847)

  • 1. Multidrug-resistant tuberculosis in Finland: treatment outcome and the role of whole-genome sequencing.
    Korhonen V; Kivelä P; Haanperä M; Soini H; Vasankari T
    ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36451847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China.
    Wang J; Yu C; Xu Y; Chen Z; Qiu W; Chen S; Pei H; Zhong Y
    Infect Drug Resist; 2023; 16():5783-5798. PubMed ID: 37692467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of efflux pump genes in extensively drug-resistant isolates of Mycobacterium tuberculosis.
    Kanji A; Hasan R; Zhang Y; Shi W; Imtiaz K; Iqbal K; Shafiq S; Hasan Z
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S150. PubMed ID: 28043519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y; Bo D; Lin X; Chen T; He T; Lin Y
    BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
    Lempens P; Decroo T; Aung KJM; Hossain MA; Rigouts L; Meehan CJ; Van Deun A; de Jong BC
    Int J Infect Dis; 2020 Nov; 100():357-365. PubMed ID: 32829049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
    Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
    PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
    Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
    Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis.
    Zhang Y; Zhao R; Zhang Z; Liu Q; Zhang A; Ren Q; Li S; Long X; Xu H
    Infect Drug Resist; 2021; 14():4375-4393. PubMed ID: 34729015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of
    He G; Zheng Q; Shi J; Wu L; Huang B; Yang Y
    Microbiol Spectr; 2024 Jun; ():e0334123. PubMed ID: 38904370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
    Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
    Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.